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Abstract
Background: Uterine carcinosarcoma (UCS) represents a true example of cancer associated with epithelial-mesenchymal
transition (EMT), which exhibits cancer stem cell (CSC)-like traits. Both Sox and β-catenin signal transductions play key
roles in the regulation of EMT/CSC properties, but little is known about their involvement in UCS tumorigenesis. Herein,
we focused on the functional roles of the Sox/β-catenin pathway in UCSs.
Methods: EMT/CSC tests and transfection experiments were carried out using three endometrial carcinoma (Em Ca)
cell lines. Immunohistochemical investigation was also applied for a total of 32 UCSs.
Results: Em Ca cells cultured in STK2, a serum-free medium for mesenchymal stem cells, underwent changes
in morphology toward an EMT appearance through downregulation of E-cadherin, along with upregulation of
Slug, known as a target gene of β-catenin. The cells also showed CSC properties with an increase in the
aldehyde dehydrogenase (ALDH) 1high activity population and spheroid formation, as well as upregulation of
Sox4, Sox7, and Sox9. Of these Sox factors, overexpression of Sox4 dramatically led to transactivation of the
Slug promoter, and the effects were further enhanced by cotransfection of Sox7 or Sox9. Sox4 was also able
to promote β-catenin-mediated transcription of the Slug gene through formation of transcriptional complexes
with β-catenin and p300, independent of TCF4 status. In clinical samples, both nuclear β-catenin and Slug
scores were significantly higher in the sarcomatous elements as compared to carcinomatous components in
UCSs, and were positively correlated with Sox4, Sox7, and Sox9 scores.
Conclusions: These findings suggested that Sox4, as well as Sox7 and Sox9, may contribute to regulation of
EMT/CSC properties to promote development of sarcomatous components in UCSs through transcriptional regulation
of the Slug gene by cooperating with the β-catenin/p300 signal pathway.
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Background
Uterine carcinosarcomas (UCSs), previously referred
to as malignant mixed mullerian tumors, are aggres-
sive neoplasms that contain both carcinomatous and
sarcomatous elements, and the incidence is only 2–5 % of
all uterine carcinomas [1, 2]. Clinically, more than 40 % of
patients with UCSs are categorized as advanced stage at
diagnosis, and over 50 % of cases show recurrence of the
disease [3]. Histopathologically, the most common epithe-
lial components are serous, followed by endometrioid
type, while the sarcomatous components are composed of
homologous (composed of tissues normally found in the
uterus) or heterologous tissues (containing tissues not
normally found in the uterus, most commonly malignant
cartilage and skeletal muscle) [4, 5].
Epithelial-mesenchymal transition (EMT) plays a cen-
tral role in converting both normal and neoplastic epi-
thelial cells into derivatives with a more mesenchymal
phenotype [6, 7]. A hallmark of EMT is loss of cell-cell
adhesion molecules, down-regulation of epithelial dif-
ferentiation markers, and transcriptional induction of
mesenchymal markers, along with nuclear localization
of β-catenin [8]. Snail, Slug, and Twist, all repressors
of the E-cadherin gene, are also involved in the
process [9–12]. Given that UCSs are regarded as
metaplastic carcinomas when the sarcomatous com-
ponent is derived from the carcinoma, it is suggested
that EMT may play an important role in tumorigenesis of
UCSs.
A growing body of evidence shows that tumors con-
tain a very small subpopulation of cancer stem cells
(CSCs) or tumor-initiating cells [13]. CSCs, similar to
somatic stem cells, are defined as cells within a tumor
that possess the capacity to self-renew and to differenti-
ate into the heterogeneous lineages of cancer cells
that comprise the tumors [14]. Interestingly, a rela-
tionship between EMT and CSCs has been proposed
with evidence demonstrating that EMT cells exhibit
stem cell-like traits and CSCs acquire mesenchymal-
like characteristics, [14] pointing to the possibility that
sarcomatous stem-like cells derived from carcinoma cells
may also be present and act as progenitors for divergent
sarcomatous differentiation.
Both Sox and β-catenin signal transductions display a
broad spectrum of biological function in the regulation
of EMT/CSC properties in a wide variety of cells
[15–17]. We therefore hypothesize that this signal
pathway may contribute to the determination of pheno-
typic characteristics through modulation of EMT/CSC
properties in UCSs. To test this, we hereby investigated
the expression of several Sox factors, β-catenin, and
Slug, with reference to EMT/CSC properties, using
endometrial carcinoma (EmCa) cell lines and clinical
UCS samples.
Methods
Plasmids and cell lines
The pGL3B-Slug luc constructs, including −2125/−235 bp,




form of TCF4), pG5 luc, and pM-β-cateninΔS45 were used
as described previously [18–21]. pM-Sox4 was constructed
by inserting the Sox4 cDNA fragment into the pM DNA-
BD vector (BD Biosciences Clontech, Worcester, MA,
USA). Site-directed mutagenesis of putative Sox4 binding
sites in the Slug promoter was performed using the PrimeS-
TAR Mutagenesis Basal kit (Takara Bio, Shiga, Japan).
The Em Ca cell lines, Ishikawa, Hec251, and Hec6 cells,
were maintained in Eagle’s MEM with 10 % bovine calf
serum. To establish cells stably overexpressing HA-Slug,
the expression plasmids or empty vectors were transfected
into Hec6 cells, and stable clones were established as
described previously [20].
Antibodies and reagents
Anti-β-catenin and anti-p27kip1 antibodies were purchased
from BD Biosciences (San Jose, CA, USA). Anti-Sox4,
anti-Sox6, anti-Sox7, anti-Sox9, anti-Sox11, and β-actin
antibodies were obtained from Sigma-Aldrich Chemicals
(St. Louis, MO, USA). Anti-Snail and anti-Slug antibodies
were from Cell Signaling (Danvers, MA, USA). Anti-
p21waf1, anti-cyclin D1, and anti-CD44s antibodies were
purchased from Dako (Copenhagen, Denmark). Anti-
Sox2 and anti-cyclin A antibodies were from Abcam
(Cambridge, MA, USA) and Novocastra (Newcastle,
UK), respectively. Anti-HA and anti-E-cadherin anti-
bodies were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA) and Takara (Shiga, Japan) respect-
ively. Anti-CD133 antibody was from Miltenyi Biotechnol-
ogy (Bergisch Gladbach, Germany).
STK2, which is a serum-free culture medium for
mesenchymal stem cells, [22] was obtained from DS
Pharma Biomedical (Osaka, Japan).
Transfection
Transfection was carried out using LipofectAMINE PLUS
(Invitrogen, Carlsbad, CA, USA) in duplicate or triplicate
as described previously [18–21]. Luciferase activity was
assayed as described previously [18–21].
Real-time reverse-transcription polymerase chain reaction
(RT-PCR)
cDNA was synthesized from 2 μg of total RNA. For
quantitative analysis, real-time RT-PCR was carried out
using a Power SYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA, USA) with specific primers
(Table 1). Fluorescent signals were detected using the
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ABI 7500 real-time PCR System, and data were analyzed
using the associated ABI 7500 System SDS Software
(Applied Biosystems). Primers for the GAPDH gene were
also applied, as described previously [18–21].
Western blot assay and immunoprecipitation
Total cellular proteins were isolated using RIPA buffer
[20 mM Tris–HCl (pH7.2), 1 % Nonidet P-40, 0.5 % so-
dium deoxycholate, 0.1 % sodium dodecyl sulfate]. Aliquots
of the proteins were resolved by SDS-PAGE, transferred to
membranes, and probed with primary antibodies, coupled
with the ECL detection system (Amersham Pharmacia Bio-
technology, Tokyo, Japan).
For immunoprecipitation, cells cultured in STK2 were
lysed with TNE buffer [10 mM Tris–HCl (pH7.6), 150 mM
NaCl, 1 % NP-40, 1 mM EDTA]. Cell lysates were cleared
and incubated with anti-Sox4 antibody, followed by incu-
bation with Protein G-Sepharose (Amersham Pharmacia
Biotechnology). Western blot assay was subsequently per-
formed with anti-β-catenin and anti-Sox4 antibodies.
Flow cytometry and Aldefluor assay
Cells were fixed using 70 % alcohol and stained with
propidium iodide (Sigma) for cell cycle analysis. ALDH
1 enzyme activity in viable cells was determined using a
fluorogenic dye based Aldefluor assay (Stem Cell Tech-
nologies, Grenoble, France) according to the manufac-
turer’s instructions. The prepared cells were analyzed by
flow cytometry using BD FACS Calibur (BD Biosciences)
and CellQuest Pro software version 3.3 (BD Biosciences).
Spheroid assay
Cells (x103) were plated in low cell binding plates
(Thermo Fisher Scientific, Yokohama, Japan) in STK2 or
Eagle’s MEM with 10 % bovine calf serum. Uniform
spheroids of at least 50 μm in size were counted ap-
proximately 2 weeks after plating.
Table 1 Primer sequences used in the study
Assay Gene/region Sequence Size








ChIP Slug/Sox4-1 Forward 5′-GTGTTATAACTACCAGCAAA-3′ 132 bp
Reverse 5′-ACAAATATAGCACAGTTGAG-3′
Slug/Sox4-2 Forward 5′-TCTCCTGCAAGTACAGTTCC-3′ 149 bp
Reverse 5′-TGTTTGGAGGGTGAGGTGG-3′
Slug/Sox4-3 Forward 5′-AGTGACTGTTGGAAGAAATA-3′ 141 bp
Reverse 5′-AAAGTGCATTGTCAGGTTG-3′
Slug/Sox4-4 Forward 5′-TCAGCCTGCCTTTAGAGGGC-3′ 121 bp
Reverse 5′-GCTACTCAGGGCTTCCGCG-3′
mRNA Slug Forward 5′-ACGCAATCAATGTTTACTCG-3′ 277 bp
Reverse 5′-TGAAGAGAAAGGTTACTGTC-3′
E-Cadherin Forward 5′-CAACATGGGAGGTGAGAGTTT-3′ 319 bp
Reverse 5′-CGAAGAAACAGCAAGAGCAGCAGAATCAGA-3′
Sox4 Forward 5′-GTTCGGCGTGTGCTTGGC-3′ 261 bp
Reverse 5′-GTCTTGCACCAGCTCGGG-3′
Sox7 Forward 5′-AAGCCCTCTCCACTGTAGCC-3′ 245 bp
Reverse 5′-TTGCGATCCATGTCCCCCAG-3′
Sox9 Forward 5′-CAGCAAGAACAAGCCGCACG-3′ 222 bp
Reverse 5′-GTAATCCGGGTGGTCCTTCTT-3′
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Chromatin immunoprecipitation (ChlP) assay
ChIP analysis was performed using an EpiXplore ChIP
assay kit (Clontech Laboratory, Mountain View, CA,
USA). Briefly, after culture in STK2 for 1 week, cells
were cross-linked with formaldehyde. Cell lysates were
sonicated to shear DNA to lengths between 200 and
1000 bp, and then precipitated overnight using anti-Sox4
antibody or rabbit IgG as negative control, along with
magnetic beads. After proteinase K digestion, DNA was
extracted and analyzed by PCR. ChIP analysis was con-
ducted with a reduction in the number of cycles from 30
to 25, using four specific primer sets.
Clinical cases
We reviewed cases of comprehensively staged high-grade
endometrial adenocarcinomas from the patient records of
Kitasato University Hospital in the period from 1997 to
2012. According to the criteria of the 2014 World Health
Organization classification, [23] tumors were designated
as UCS if they had evidence of both malignant epithelial
(endometrioid, serous, or clear cell) components and
mesenchymal (homologous or heterologous) elements.
Endometrioid adenocarcinomas with spindle elements
and hyalinized stroma were specifically excluded. Finally, a
total of 32 UCSs were investigated. Of these, 9 cases had
endometrioid and 23 cases had non-endometrioid epi-
thelial components, while 25 and 8 cases showed
homologous and heterologous mesenchymal elements,
respectively. All tissues were routinely fixed in 10 %
formalin and processed for embedding in paraffin wax.
Approval for this study was given by the Ethics Commit-
tee of the Kitasato University School of Medicine (B14-
35). Signed informed consent forms were not required
from the participants due to the retrospective approach of
the study, which did not impact on their treatment.
Immunohistochemistry (IHC)
IHC was performed using a combination of the microwave-
oven heating and polymer immunocomplex (Envision,
Dako) methods, as described previously [18–21]. The
immunoreactions were visualized with DAB (3,3′ di-
aminobenzidine), and the nuclei were counterstained
with methyl green.
For evaluation of IHC findings, scoring of nuclear immu-
noreactivity was performed, on the basis of the percentage
of immunopositive cells and the immunointensity, with
multiplication of values of the two parameters, as described
previously [18–21].
Statistics
Comparative data were analyzed using the Mann–Whitney
U-test, and the Spearman’s correlation coefficient. The cut-
off for statistical significance was set as p < 0.05.
Results
Changes in expression of Sox factors during the EMT
process in Em Ca cells
To induce EMT in Em Ca cells, the three cell lines, in-
cluding Ishikawa, Hec251, and Hec6 cells, were cultured
in STK2, a serum-free medium for mesenchymal stem
cells [22]. As shown in Fig. 1a, cells cultured in STK2
demonstrated a dramatically altered morphology to-
ward a fibroblast-like appearance after 73 h, along with
decreased E-cadherin and increased Slug expression at
both mRNA and protein levels (Fig. 1b and c). In con-
trast, changes in Snail expression at the protein level
(Fig. 1b), as well as the mRNA level, were relatively
weak (data not shown).
Next, we examined whether Sox factors are directly in-
volved in regulation of the EMT process observed in cells
cultured in STK2, since some molecules are involved in
the promotion of EMT [15]. The Ishikawa, Hec251, and
Hec6 cells cultured in STK2 showed increased expression
of Sox4, Sox7, and Sox9, but not Sox6 and Sox11, at both
protein and mRNA levels (Fig. 1d and e). In addition, the
Sox4 promoter activity was increased by 20–50 folds
following transfection of Sox7, while changes in the pro-
moter activity of both Sox7 and Sox9 in response to other
Sox factors were relatively minor (Fig. 1f and Additional
file 1: Figure S1A). These findings suggested that culturing
Em Ca cells in STK2 was sufficient to induce EMT, along
with downregulation of E-cadherin and upregulation
of Slug. In addition, upregulation of some Sox factors
through formation of complex transcriptional regulatory
loops occurs during the EMT process in Em Ca cells.
Relationship between EMT and CSC properties in Em Ca
cells
To examine whether EMT is linked to CSC properties,
Hec6 cells were selected since they showed higher Slug
expression as compared to those in Ishikawa and Hecc251
cells after culturing in STK2 (Fig. 1b). Cultured Hec6 cells
had a low cell proliferation rate, particularly in the expo-
nential growth phase, which correlated with increased
p21waf1 but not p27Kip1 expression, and a decreased S-
fraction during cell cycle progression (Fig. 2a). The inhibi-
tory effects were also observed in Ishikawa and Hec251
cells (data not shown). Aldefluor assay revealed an in-
crease in the ALDH1high activity population (Fig. 2b),
in line with the significantly increased number of well-
defined, round spheroids that were over 50 um in size
(Fig. 2c). In addition, expression of other CSC markers,
including CD44s and Sox2, but not CD133, was also
increased in Hec6 cells as well as Ishikawa and Hec251
cells cultured in STK2 (Additional file 1: Figure S1B).
These findings indicated that the Em Ca cells cultured in
STK2 exhibited EMT/CSC properties.
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Slug is associated with EMT/CSC properties in Em Ca cells
To examine whether Slug is directly linked to induction
of EMT/CSC properties, two independent Hec6 cell
lines stably overexpressing Slug (H6SL#8 and #21) were
established. The stable cells underwent a dramatic change
in morphology to fibroblast-like mesenchymal features
with decreased E-cadherin expression, independent of
Snail status (Fig. 2d). In H6SL#8 cells, the proliferative
activity was extremely low, along with an inhibition of the
S- to G2/M-phase during cell cycle progression (Fig. 2e).
In addition, the ALDH1high activity population was in-
creased in the stable cells (Fig. 2f). However, changes in
expression of Sox4, Sox7, and Sox9 were relatively minor
in H6SL#8 cells as compared to the mock (Additional
file 1: Figure S1C). These findings suggested that ex-
ogenous overexpression of Slug is sufficient in induction
of EMT/CSC properties in Em Ca cells, independent of
Sox factors.
Transcriptional regulation of the Slug gene by Sox factors
in Em Ca cells
To examine whether Sox factors are directly involved in
transcription of the Slug gene, the three Sox factors,
whose expression was differentially regulated by culturing
in STK2, were transfected into three Em Ca cell lines.
Transient transfection of Sox4 resulted in increased activ-
ity of the Slug promoter, along with increased mRNA
levels, which were further enhanced by cotransfection of
Sox7 or Sox9. In contrast, such effects were relatively
minor when only Sox7 and/or Sox9 were transfected
(Fig. 3a and Additional file 2: Figure S2A and B).
Analysis of an approximately 2000 bp fragment up-
stream of the translation start site in the Slug gene
(AF084243) revealed four potential Sox4-binding elements
(BE) (A/T A/T CAA A/T G) (Fig. 3b). Using a series of
5′-truncated promoter constructs, we found that deletion
from −2125 to −1587 bp had little effect on induction of
Fig. 1 Changes in expression of Sox factors during the EMT process in Em Ca cells. a Phase-contrast images of Ishikawa, Hec251, and
Hec6 cells cultured in STK2 for 5 days. Western blot analysis (b) and real time RT-PCR (c) for the indicated molecules from Ishikawa,
Hec251, and Hec6 cells cultured in STK2. Con and c, control; s, STK2; Ish, Ishikawa cells. d Western blot analysis for the indicated proteins
from Ishikawa, Hec251, and Hec6 cells cultured in STK2. Con, control. e Real time RT-PCR for the indicated mRNA transcripts from Ishikawa, Hec251,
and Hec6 cells cultured in STK2. c, control; s, STK2. f Hec6 cells were transfected with Sox4, Sox7, and Sox9 reporter constructs, together
with either Sox4, Sox7, or Sox9. Relative activity was determined based on arbitrary light units of luciferase activity normalized to pRL-TK
activity. The activities of the reporter plus the effector relative to that of the reporter plus empty vector are shown as means ± SDs. The
experiment was performed in duplicate
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the promoter activity by Sox4, as well as Sox7 and Sox9,
whereas the -813/-235 bp deletion appeared to have pre-
vented binding of the Sox factors and reduced the pro-
moter activity to a very low level (Fig. 3c and Additional
file 2: Figure S2C). This indicated that the region involved
in the response to Sox4 is present between −2125 to
−813 bp. Additional promoter constructs carrying four
nucleotide alterations in all of the putative Sox4-binding
sites, including Sox4-1, Sox4-2, Sox4-3, and Sox4-4 (Fig. 3b),
resulted in considerable reduction of response to Sox4
(Fig. 3d). ChIP assays revealed that increased amount of
Sox4 by STK2 culture caused its recruitment to these four
Sox4-BEs within the promoter (Fig. 3e). These findings
suggest that Slug is a target gene of Sox4.
Association between β-catenin and Sox4 on transcrip-
tional regulation of the Slug gene in Em Ca cells
Since it has been reported that β-catenin is a positive
regulator of Slug expression, [18] we examined for an
association between Sox4 and β-catenin in regulation of
the Slug promoter. The promoter activity was increased
by a combination of β-catenin and Sox4, and the effect
was further enhanced by cotransfection of the multifunc-
tional coactivator p300, but not by dominant-negative
TCF4 (Fig. 4a and Additional file 3: Figure S3A). Cotrans-
fection of GFP-Sox4, HA-β-cateninΔS45, and Flag-p300
resulted in formation of several enlarged dots in the
nuclei (Fig. 4b), whereas such nuclear aggregates were
not observed after cotransfection of GFP-Sox4 and HA-β-
Fig. 2 Association between Slug expression and EMT/CSC properties in Em Ca cells. a Upper left: Hec6 cells were seeded at low density with
or without STK2. The cell numbers are presented as means ± SDs. P0, P3, P5, and P7 indicate 0, 3, 5, and 7 days after cell passage, respectively.
Upper right: western blot analysis for the indicated proteins from Hec6 cells cultured in STK2. Lower: cell cycle analysis of Hec6 cells cultured in
STK2 for 6 days by flow cytometry. Con, control. b Aldefluor analysis of Hec6 cells cultured in STK2 (lower) and its control (upper) for
5 days. Cells negative for ALDH activity (treated with ALDH inhibitor DEAB) are located in the area to the far left of each plot, and the
positive cells are in black gates (R1 and R2). The percentage of live single cell population contained in each gate is shown. DEAB,
diethylaminobenzaldehyde. c Left: phase-contrast images of spheroids of Hec6 cells cultured in STK2 for 2 weeks. Right: the number of
spheroids is presented as means ± SDs. Con, control. d Left: phase-contrast images of two independent Hec6 cell lines stably overexpress-
ing Slug (H6SL#8 and #21) and mock-transfected cells. Right: western blot analysis for the indicated proteins from H6SL#8 and #21 cells
and the mock. e Upper: H6SL#8 cells were seeded at low density. The cell numbers are presented as means ± SDs. P0, P3, P5, P7, and P9
indicate 0, 3, 5, 7, and 9 days after cell passage, respectively. Lower: cell cycle analysis of H6SL#8 and mock cells at 7 days by flow cytometry. f Aldefluor
analysis of H6SL#8 (lower) and mock (upper) cells. Cells negative for ALDH activity (treated with ALDH inhibitor DEAB) are located in the area to the far
left of each plot, and the positive cells are in black gates (R1 and R2). The percentage of live single cell population contained in each gate is shown.
DEAB, diethylaminobenzaldehyde
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cateninΔS45 alone (Additional file 3: Figure S3B). One-
hybrid assays revealed that the pG5 luc reporter activity
was raised by 3–12 folds following cotransfection of either
DNA-BD-fused full-length β-catenin or Sox4 fragment
(pM-β-cat or pM-Sox4) and p300, but such effects were
relatively minor with cotransfection of only pM-β-catenin
and Sox4, Sox7 or Sox9 (Fig. 4c and Additional file 3:
Figure S3C and D). Finally, coimmunoprecipitation using
lysates of cells cultured in STK2 revealed a weak inter-
action between β-catenin and Sox4 (Fig. 4d). These find-
ings suggested that Sox4 cooperates with β-catenin/p300
complexes in the transcriptional regulation of the Slug
gene.
Immunohistochemical (IHC) findings in UCSs
Representative images of IHC findings for Slug, β-catenin,
and Sox factors are illustrated in Fig. 5a. Distinct nuclear
immunostaining for Slug, Sox4, Sox7, and Sox9, and nu-
clear and cytoplasmic/membranous immunoreaction for
β-catenin were observed in both the carcinomatous and
sarcomatous components of UCSs. Average nuclear β-
catenin and Slug scores were significantly higher in the
sarcomatous elements than those in the carcinomatous
components, in contrast to no significant differences in
the scores of Sox4, Sox7, and Sox9 (Fig. 5b). The average
Slug score was positively correlated with nuclear β-catenin
score and combinations of the three Sox factors, including
Sox4/Sox9, Sox7/Sox9, and Sox4/Sox7/Sox9. The nuclear
β-catenin score also showed a positive correlation with
combinations of the three Sox factors (Table 2).
Discussion
The present study clearly provided evidence for a close
link between EMT and CSC properties in Em Ca cells.
Fig. 3 Transcriptional up-regulation of the Slug gene by Sox4. a Left: Hec6 cells were transfected with Slug reporter constructs, together with Sox4,
Sox7, and Sox9, respectively. Relative activity was determined based on arbitrary light units of luciferase activity normalized to pRL-TK activity. The
activities of the reporter plus the effector relative to that of the reporter plus empty vector are shown as means ± SDs. Right: analysis of mRNA levels
for the Slug gene with total RNA extracted from Hec6 cells after transfection of Sox4, Sox7, and Sox9 using real time RT-PCR assays. The experiment
was performed in triplicate. b The Slug promoter sequence containing four putative Sox4-binding sites including Sox4-1, Sox4-2, Sox4-3, and Sox4-4
sites. c, d Various promoter constructs were used for evaluating transcriptional regulation of the Slug promoter by Sox4, Sox7, and Sox9. The experiment
was performed in triplicate. e ChIP assay data showing that Sox4 is bound to Slug promoter regions, in particular after culturing in STK2 for 3 days
Inoue et al. BMC Cancer  (2016) 16:53 Page 7 of 11
We found that culturing Em Ca cells in STK2 was suffi-
cient to induce EMT, as demonstrated by the acquire-
ment of a spindle-like morphology as well as decreased
E-cadherin and increased Slug expression. The IHC data
also demonstrated a significantly higher Slug score in
sarcomatous elements relative to carcinomatous compo-
nents of UCSs. Further, the cell proliferation rates were
significantly decreased during the process, in line with
the report showing that Snail-expressing epithelial cells
undergoing EMT have a low proliferation potential [24].
The cells cultured in STK2 also showed stem cell prop-
erties as evidenced by an increase in the ALDH1high cell
population and the number of spheroid formation. Given
that EMT leads to a greater number of self-renewing cells
that can initiate the seeding of spheroids with enriched
stem cells, [14] it is likely that mesenchymal stem-like
cells derived from carcinoma cells may be necessary for
establishment of the sarcomatous components in UCSs.
In addition to EMT/CSC properties, the Em Ca cells
cultured in STK2 also exhibited simultaneous upregula-
tion of Sox4, Sox7, and Sox9. Interestingly, the Sox4 pro-
moter activity was drastically increased by transfection of
Sox7, in line with the IHC data showing significant posi-
tive correlation between the two in UCS tissues. Although
both Sox7 and Sox9 promoters were also weakly activated
by either Sox4, Sox7, or Sox9 in Hec6 cells, such associa-
tions were absent in UCS tissues. Given the evidence that
expression of Sox genes themselves is frequently subjected
to auto-regulation or control by other Sox proteins, [25] it
appeared that complex regulatory loops among these Sox
factors including the Sox7/Sox4 axis may be activated
during the EMT/CSC process.
Fig. 4 Interaction among β-catenin, Sox4, and p300 in Em Ca cells. a Ishikawa cells were transfected with Slug reporter constructs, together with
β-cateninΔS45 (β-cat), Sox4, p300, and dominant-negative TCF4 (ΔNTCF4). Relative activity was determined based on arbitrary light units of luciferase
activity normalized to pRL-TK activity. The activities of the reporter plus the effector relative to that of the reporter plus empty vector are shown as
means ± SDs. The experiment was performed in duplicate. b After transfection of HA-β-cateninΔS45, GFP-Sox4, and Flag-p300, Ishikawa cell were
stained with anti-HA antibody (upper) or a combination of anti-HA and anti-Flag antibodies (lower). Immunopositive cells are indicated by arrows.
Nuclei were stained with DAPI. c Ishikawa cells were transfected with pM-β-catenin (left) or pM-Sox4 (right), along with pGL5 luc, Sox4, Sox7, Sox9, and
p300. The experiment was performed in duplicate. d Coimmunoprecipitation of β-catenin and Sox4 in Ishikawa, Hec251, and Hec6 cells cultured in
STK2 for 5 days. IP, immunoprecipitation
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Fig. 5 IHC findings in serial sections of UCS. a Staining by hematoxylin and eosin (HE) and by IHC for the indicated molecules. Note the predominant
nuclear immunopositivity for Slug and β-catenin in sarcomatous components, but not carcinomatous lesions. Various combinations of nuclear
immunopositivity for Sox4, Sox7, and Sox9 are also observed in both sarcomatous and carcinomatous components. Carcinomatous components are
indicated by arrows. Sarcomatous components are magnified in the insets. Original magnification, x200 and x400 (insets). (Sa +/-), immunopositive or
immunonegative in sarcomatous components; (Ca +/-), immunopositive or immunonegative in carcinomatous components. b IHC scores
for the indicated molecules in carcinomatous (Ca) and sarcomatous (Sa) components of UCSs. The data shown are means ± SDs
Table 2 Correlations among IHC markers investigated in uterine carcinosarcomas
Slug N-β-catenin Sox4 Sox7 Sox9 Sox4 + Sox7 Sox4 + Sox9 Sox7 + Sox9
ρ (p) ρ (p) ρ (p) ρ (p) ρ (p) ρ (p) ρ (p) ρ (p)
N-β-catenin 0.59 (<0.0001) * * * * * * *
Sox4 0.27 (0.08) 0.25 (0.1) * * * * * *
Sox7 0.3 (0.06) 0.46 (0.004) 0.42 (0.006) * * * * *
Sox9 0.26 (0.22) 0.21 (0.07) 0.15 (0.48) 0.32 (0.14) * * * *
Sox4 + Sox7 0.3 (0.05) 0.32 (0.04) 0.87 (<0.0001) 0.78 (<0.0001) 0.3 (0.18) * * *
Sox4 + Sox9 0.49 (0.03) 0.57 (0.009) 0.84 (<0.0001) 0.43 (0.04) 0.59 (0.004) 0.79 (0.0003) * *
Sox7 + Sox9 0.47 (0.05) 0.65 (0.005) 0.44 (0.04) 0.9 (<0.0001) 0.64 (0.003) 0.76 (0.0005) 0.58 (0.008) *
Sox4 + Sox7 + Sox9 0.59 (0.01) 0.71 (0.001) 0.8 (0.0002) 0.82 (0.0002) 0.5 (0.02) 0.95 (<0.0001) 0.85 (0.0001) 0.87 (<0.0001)
ρ Spearman’s correlation coeffcient, N nuclear, *, not examined
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Unexpectedly, we found that Hec6 cells stably overex-
pressing Slug did not show any changes in expression of
Sox4, Sox7, and Sox9, although the cells displayed EMT/
CSC properties. This may be because Sox factors are
upstream of Slug and thus are no longer required for the
process in cells exogenously overexpressing Slug. In
addition, it is also unexpected that there were no signifi-
cant differences in the Sox factor scores between sarcoma-
tous and carcinomatous components in UCSs, although
combinations of the Sox factors showed positive correla-
tions with both Slug and nuclear β-catenin scores. At
the present time, although we are unable to provide
an appropriate explanation for the observation, one
possible reason may be that various post-translational
modifications modulate the activity, stability, and intracel-
lular localization of some Sox proteins. For example, some
Sox factors are subject to various covalent modifications
such as phosphorylation, sumoylation, acetylation, methy-
lation, and glycosylation [26–31]. Further studies to clarify
these points are clearly warranted.
Several lines of evidence from the present study support
the conclusion that Sox4 contributes to transcriptional
control of the Slug gene. First, overexpression of both Slug
and Sox4 occurred in Em Ca cells cultured in STK2.
Second, transient transfection of Sox4 caused an increase
in Slug mRNA expression, in line with activation of its
promoter. Third, Sox4 could bind to the promoter region
of the Slug gene from −2125 to −813 bp, probably through
its interaction with four putative Sox4-BEs. The effects
were further enhanced by cotransfection of Sox9 and/or
Sox7. Interestingly, it has been recently reported that
ectopic Sox4 expression in human mammary epithelial
cells could induce a mesenchymal phenotype, which was
associated with increased stem cell properties, cellular
migration, and invasion in vitro [32].
Sox proteins generally exhibit gene regulatory functions
only by forming complexes with partner transcription
factors [25]. Transcriptional activity and target gene speci-
ficity of Sox4 are also considered to be controlled through
cooperative interactions with distinct transcription fac-
tors and cofactors [33]. In this study, Sox4 was able to
enhance β-catenin-mediated transcription of the Slug
gene through formation of transcriptional complexes in-
cluding β-catenin, Sox4, and p300. Although Sox4 has
been demonstrated to directly interact with TCF4 via their
respective HMG domain by in vitro protein-binding assay,
[34] our present data revealed that activation of the Slug
promoter by Sox4, as well as β-catenin, was not abrogated
by dominant-negative TCF4, indicating that the ob-
served activation did not require TCF4-binding sites in
the promoter.
Conclusions
Our observations suggest a mode of molecular mechan-
ism for establishment of sarcomatous components with
EMT/CSC properties in UCSs (Fig. 6). Upregulation of
Slug by Sox4, as well as β-catenin and p300 complexes,
induces EMT and associated CSC properties, which in
turn results in the promotion of homologus and heterol-
ogous sarcomatous components in UCSs. Increased ex-
pression of Sox7 and Sox9, as well as cooperation between
Sox7 and Sox4, also participate in the process. Thus, the
present study clearly provided evidence of a functional
role for Sox4 through its association with β-catenin and
p300 in regulation of the Slug gene during development of
the sarcomatous component in UCSs.
Additional files
Additional file 1: Figure S1. (A) Ishikawa (Ish) cells were transfected
with Sox4, Sox7, and Sox9 reporter constructs, together with either Sox4,
Sox7, or Sox9. Relative activity was determined based on arbitrary light
units of luciferase activity normalized to pRL-TK activity. The activities of
the reporter plus the effector relative to that of the reporter plus empty
vector are shown as means ± SDs. The experiment was performed in
duplicate. (B) Western blot analysis for the indicated proteins from Ishikawa,
Hec251, and Hec6 cells cultured in STK2. (C) Western blot analysis for the
indicated proteins from H6SL#8 and mock cells. (TIF 2816 kb)
Additional file 2: Figure S2. (A) Ishikawa (left) and Hec251 cells (right)
were transfected with Slug reporter constructs, together with Sox4, Sox7,
and Sox9. Relative activity was determined based on arbitrary light units
of luciferase activity normalized to pRL-TK activity. The activities of the
reporter plus the effector relative to that of the reporter plus empty
vector are shown as means ± SDs. (B) Analysis of mRNA levels for the
Slug gene with total RNA extracted from Hec251 cells after transfection
of Sox4, Sox7, and Sox9 using real time RT-PCR assays. The experiment
was performed in triplicate. (C) Various promoter constructs were used
for evaluating transcriptional regulation of the Slug promoter by Sox4,
Sox7, and Sox9 in Ishikawa (left) and Hec251 cells (right). The experiment
was performed in triplicate. (TIF 1198 kb)
Additional file 3: Figure S3. (A) Hec251 (left) and Hec6 cells (right)
were transfected with Slug reporter constructs, together with β-cateninΔS45
(β-cat), Sox4, and p300. Relative activity was determined based on arbitrary
light units of luciferase activity normalized to pRL-TK activity. The
activities of the reporter plus the effector relative to that of the reporter plus
empty vector are shown as means ± SDs. The experiment was performed in
duplicate. (B) After transfection of HA-β-cateninΔS45 and GFP-Sox4, cells
were stained with anti-HA antibody. Immunopositive cell is indicated by
arrow. Nuclei were stained by DAPI. (C,D) Hec251 (C) and Hec6 (D) cells
were transfected with pM-β-catenin (left) or pM-Sox4 (right), along with
pGL5 luc, Sox4, Sox7, Sox9, and p300. The experiment was performed in
duplicate. (TIF 2017 kb)
Fig. 6 Schematic representation of the association between Sox
factors and β-catenin/p300 signal networks in the establishment of
EMT/CSC properties as progenitor for divergent sarcomatous
differentiation in UCS
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